734 related articles for article (PubMed ID: 24513111)
1. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
Wallace ZS; Deshpande V; Stone JH
Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related Orbital Disease and Its Mimics in a Western Population.
Ferry JA; Klepeis V; Sohani AR; Harris NL; Preffer FI; Stone JH; Grove A; Deshpande V
Am J Surg Pathol; 2015 Dec; 39(12):1688-700. PubMed ID: 26379149
[TBL] [Abstract][Full Text] [Related]
3. [IgG4-related disease: patient group characterization and rituximab therapy].
Sedyshev SKh; Vasil'ev VI; Kovrigina AM; Logvinenko OA; Rodionova EB; Safonova TN; Gaĭduk IV; Silin AIu; Komov DV; Nasonov EL
Ter Arkh; 2013; 85(2):48-53. PubMed ID: 23653939
[TBL] [Abstract][Full Text] [Related]
4. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement.
Wallace ZS; Khosroshahi A; Jakobiec FA; Deshpande V; Hatton MP; Ritter J; Ferry JA; Stone JH
Surv Ophthalmol; 2012; 57(1):26-33. PubMed ID: 22018678
[TBL] [Abstract][Full Text] [Related]
5. IgG4-related orbital disease: a meta-analysis and review.
Andrew N; Kearney D; Selva D
Acta Ophthalmol; 2013 Dec; 91(8):694-700. PubMed ID: 22963447
[TBL] [Abstract][Full Text] [Related]
6. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.
McNab AA; McKelvie P
Ophthalmic Plast Reconstr Surg; 2015; 31(3):167-78. PubMed ID: 25564258
[TBL] [Abstract][Full Text] [Related]
7. IgG4-related disease in idiopathic sclerosing orbital inflammation.
Sa HS; Lee JH; Woo KI; Kim YD
Br J Ophthalmol; 2015 Nov; 99(11):1493-7. PubMed ID: 25947555
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related disease in the eye and ocular adnexa.
Derzko-Dzulynsky L
Curr Opin Ophthalmol; 2017 Nov; 28(6):617-622. PubMed ID: 28858963
[TBL] [Abstract][Full Text] [Related]
9. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.
Campochiaro C; Ramirez GA; Bozzolo EP; Lanzillotta M; Berti A; Baldissera E; Dagna L; Praderio L; Scotti R; Tresoldi M; Roveri L; Mariani A; Balzano G; Castoldi R; Doglioni C; Sabbadini MG; Della-Torre E
Scand J Rheumatol; 2016; 45(2):135-45. PubMed ID: 26398142
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.
Park J; Lee MJ; Kim N; Kim JE; Park SW; Choung HK; Khwarg SI
Br J Ophthalmol; 2018 Jun; 102(6):736-741. PubMed ID: 28972022
[TBL] [Abstract][Full Text] [Related]
11. IgG4-related ophthalmic disease. Part I: background and pathology.
McNab AA; McKelvie P
Ophthalmic Plast Reconstr Surg; 2015; 31(2):83-8. PubMed ID: 25564257
[TBL] [Abstract][Full Text] [Related]
12. Neuro-ophthalmic complications of IgG4-related disease.
Chwalisz BK; Stone JH
Curr Opin Ophthalmol; 2018 Nov; 29(6):485-494. PubMed ID: 30199519
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.
Ebbo M; Patient M; Grados A; Groh M; Desblaches J; Hachulla E; Saadoun D; Audia S; Rigolet A; Terrier B; Perlat A; Guillaud C; Renou F; Bernit E; Costedoat-Chalumeau N; Harlé JR; Schleinitz N
Medicine (Baltimore); 2017 Mar; 96(10):e6205. PubMed ID: 28272212
[TBL] [Abstract][Full Text] [Related]
14. Successful "medical" orbital decompression with adjunctive rituximab for severe visual loss in IgG4-related orbital inflammatory disease with orbital myositis.
Chen TS; Figueira E; Lau OC; McKelvie PA; Smee RI; Dawes LC; Agar A; Wilcsek G; Francis IC
Ophthalmic Plast Reconstr Surg; 2014; 30(5):e122-5. PubMed ID: 24481505
[TBL] [Abstract][Full Text] [Related]
15. IgG4-related disease: a neuro-ophthalmological perspective.
Kashii S
J Neuroophthalmol; 2014 Dec; 34(4):400-7. PubMed ID: 25405662
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor.
Min HK; Lee YS; Yang SW; Lee J; Kwok SK; Ju JH; Kim WU; Park SH
Korean J Intern Med; 2019 Jan; 34(1):220-226. PubMed ID: 29050463
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.
Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
BMC Ophthalmol; 2021 Dec; 21(1):447. PubMed ID: 34961492
[TBL] [Abstract][Full Text] [Related]
18. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD.
Andrew NH; Sladden N; Kearney DJ; Selva D
Br J Ophthalmol; 2015 Mar; 99(3):376-81. PubMed ID: 25185258
[TBL] [Abstract][Full Text] [Related]
19. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment.
Chan ASY; Mudhar H; Shen SY; Lang SS; Fernando M; Hilmy MH; Guppy NJ; Rennie I; Dunkley L; Al Jajeh I
Br J Ophthalmol; 2017 Nov; 101(11):1576-1582. PubMed ID: 28351925
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system manifestation of IgG4-related disease.
Regev K; Nussbaum T; Cagnano E; Giladi N; Karni A
JAMA Neurol; 2014 Jun; 71(6):767-70. PubMed ID: 24781034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
